Free radicals in Alzheimer’s disease (original) (raw)
Adams IM (1991) Structural plasticity of synapses in Alzheimer’s disease. Mol Neurobiol 5: 411–419 ArticlePubMedCAS Google Scholar
Adams JD, Klaidman LK, Odunze IN, Shen HC, Miller CA (1991) Alzheimer’s disease and Parkinson’s disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neuropathol 14: 213–226 ArticleCAS Google Scholar
Adolfsson R, Gottfries C-G, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029–1034 ArticlePubMedCAS Google Scholar
Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E (1995) No evidence for systemic oxidant stress in Parkinson’s or Alzheimer’s disease. Mov Disord 10: 566–573 ArticlePubMedCAS Google Scholar
Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat 64: 146–148 Google Scholar
Andorn AC, Britton RS, Bacon BR (1990) Evidence that lipid peroxidation and total iron are increased in Alzheimer’s brain [abstract]. Neurobiol Aging 11: 316 Google Scholar
Anneren G, Gardner A, Lundin T (1986) Increased glutathion peroxidase activity in erythrocytes in patients with Alzheimer’s disease/senile dementia of Alzheimer’s type. Acta Neurol Scand 73: 586–589 ArticlePubMedCAS Google Scholar
Aruoma OI, Halliwell B, Laughton MJ, Quinlan GJ, Gutteridge JMC (1989) The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)-iron(III) complex. Biochem J 258: 617–620 PubMedCAS Google Scholar
Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White LR, D’Agostino RB (1993) Incidence of dementia and probable Alzheimer’s disease in a general population: the Framingham Study. Neurology 43: 515–519 ArticlePubMedCAS Google Scholar
Balazs L, Leon M (1994) Evidence of an oxidative challenge in the Alzheimer’s brain. Neurochem Res 19: 1131–1137 ArticlePubMedCAS Google Scholar
Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR (1994) In vivo evaluation of brain iron in Alzheimer’s disease and normal subjects using MRI. Biol Psychiatry 35: 480–487 ArticlePubMedCAS Google Scholar
Bauer J (1994) Die Alzheimer Krankheit. Neurobiologie, Psychosomatik, Diagnostik und Therapie. Schattauer, Stuttgart Google Scholar
Bauer J, Berger M (1993) Neuropathologie, Immunologie und psychobiologische Aspekte der Alzheimer Krankheit. Fortschr Neurol Psychiatr 61: 225–240 ArticlePubMedCAS Google Scholar
Banyes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405–412 Article Google Scholar
Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38: 357–366 ArticlePubMedCAS Google Scholar
Beal MF (1996) Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol 6: 661–666 ArticlePubMedCAS Google Scholar
Benzi G, Moretti A (1995) Are reactive oxygen species involved in Alzheimer’s disease? Neurobiol Aging 16: 661–674 ArticlePubMedCAS Google Scholar
Benzi G, Marzatico F, Pastoris O, Villa RF (1989) Influence of oxidative stress on the age-linked alterations of the cerebral glutathione system. J Neurosci Res 26: 120–128 Article Google Scholar
Blass JP, Baker AC, Ko L, Black RS (1990) Induction of Alzheimer antigen an uncoupler of oxidative phosphorylation. Arch Neurol 47: 864–869 ArticlePubMedCAS Google Scholar
Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239–259 ArticlePubMedCAS Google Scholar
Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378: 776–779 ArticlePubMedCAS Google Scholar
Ceballos-Picot I, Merad-Boudia M, Nicole A, Thevenin M, Hellier G, Legrain S, Berr C (1996) Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer’s type — place of the extracellular glutathion peroxidase. Free Radic Biol Med 20: 579–587 ArticlePubMedCAS Google Scholar
Chen L, Richardson JS, Caldwell JE, Ang LC (1994) Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer’s disease and from nondemented controls. Int J Neurosci 75: 83–90 ArticlePubMedCAS Google Scholar
Colton CA, Gilbert DL (1987) Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223: 284–288 ArticlePubMedCAS Google Scholar
Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ (1992a) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer’s disease. J Neurosci Res 31: 327–335 ArticlePubMedCAS Google Scholar
Connor JR, Menzies SL, St. Martin SM, Mufson EJ (1992b) A histochemical study of iron, transferrin, and ferritin in Alzheimer’s diseased brains. Neurosci Res 31: 75–83 ArticleCAS Google Scholar
Connor JR, Tucker P, Johnson M, Snyder B (1993) Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer’s disease. Neurosci Lett 159: 88–90 ArticlePubMedCAS Google Scholar
Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G (1988) Platelet MAO-B activity and the psychopathology of Parkinson’s disease, senile dementia and multiinfarct dementia. Acta Psychiatr Scand 78: 730–736 ArticlePubMedCAS Google Scholar
Delamarche C (1989) A homologous domain between the amyloid protein of Alzheimer’s disease and the neurofilament subunits. Biochimie 71: 853–856 ArticlePubMedCAS Google Scholar
Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther KE (1992) Amyloidogenicity of β A4 and β A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 267: 18210–18217 PubMedCAS Google Scholar
Ebrahim S, Schupf S, Silverman W, Zigman WB, Moretz RC, Wisniewski HM, Taylor E, Devakumar M, Lindegard B, Lindesay J, Grant DJ, McMurdo MET, Corrigan FM, Reynolds GP, Ward NI, Farrar G, Blair JA, Curran S, Hindmarch I, Steer C (1989) Aluminium and Alzheimer’s disease. Lancet ii: 267–269 Article Google Scholar
Ehmann WD, Markesbery WR, Alauddin M, Hossain TIM, Brubaker EH (1986) Brain trace elements in Alzheimer’s disease. Neurotoxicology 7: 195–206 PubMedCAS Google Scholar
Fischer P, Götz ME, Ellinger B, Streifler M, Riederer P, Danielczyk W (1994) Platelet monoamine oxidase B activity and vitamin B12 in dementia. Biol Psychiat 35: 772–774 ArticlePubMedCAS Google Scholar
Fleming J, Joshi JG (1987) Ferritin: isolation of aluminium-ferritin complex from brain. Proc Natl Acad Sci 84: 7866–7870 ArticlePubMedCAS Google Scholar
Frölich L, Riederer P (1995) Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. Arzneimittelforschung 43: 443–446 Google Scholar
Gautrin D, Gauthier S (1989) Alzheimer’s disaese: environmental factors and etiologic hypothesis. Can J Neurol Sci 16: 375–387 PubMedCAS Google Scholar
Gerlach M, Ben Shachar D, Riederer P, Youdim MB (1994) Altered metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63: 793–807 ArticlePubMedCAS Google Scholar
Götz ME, Freyberger A, Hauer E, Burger R, Sofic E, Gsell W, Heckers S, Jellinger K, Hebenstreit G, Frölich L, Beckmann H, Riederer P (1992) Susceptibility of brains from patients with Alzheimer’s disease to oxygen-stimulated lipid peroxidation and differential scanning calorimetry. Dementia 3: 213–222 Google Scholar
Götz ME, Dirr A, Freyberger A, Burger R, Riederer P (1993) The thiobarbituric acid assay reflects susceptibility to oxygen-induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: a methodological approach. Neurochem Int 22: 255–262 ArticlePubMed Google Scholar
Götz ME, Künig G, Riederer P, Youdim MBH (1994) Oxidative stress: free radical production in neuronal degeneration. Pharmac Ther 63: 37–122 Article Google Scholar
Götz ME, Fischer P, Gsell W, Riederer P, Streifler M, Simanyi M, Müller F, Danielczyk W (1998) Platelet monoamine oxidase B activity in dementia: a 4 Year follow up. Dementia 9: 74–77 Google Scholar
Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminium and iron in the neurofibrillary tangles of Alzheimer’s disease: a laser microprobe (LAMMA) study. Ann Neurol 31: 286–292 ArticlePubMedCAS Google Scholar
Greenamyre JT, Maragos WF (1993) Neurotransmitter receptors in Alzheimer disease. Cerebrovasc Brain Metab Rev 5: 61–94 PubMedCAS Google Scholar
Greenlund LJ, Deckwerth TL, Johnson EM Jr (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14: 303–315 ArticlePubMedCAS Google Scholar
Grootveld M, Halliwell B (1986) Aromatic hydroxylation as a potential measure of hydroxyl radical formation in vivo. Biochem J 237: 499–504 PubMedCAS Google Scholar
Grundke-Iqbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG (1990) Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl) 81: 105–110 ArticleCAS Google Scholar
Gsell W, Conrad R, Hickethier M, Sofic E, Frölich L, Wichart I, Jellinger K, Moll G, Ransmayr G, Beckmann H, Riederer P (1995) Decreased catalase activity but unchanged superoxide dismutase activity in brain of patients with dementia of Alzheimer type. J Neurochem 64: 1216–1223 ArticlePubMedCAS Google Scholar
Gutteridge JM, Quinlan GJ, Clark I, Halliwell B (1985) Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta 835: 441–447 ArticlePubMedCAS Google Scholar
Halliwell B, Gutteridge JM (1984) Oxygen toxicity, transition metals and disease. Biochem J 219: 1–14 PubMedCAS Google Scholar
Hajimohammadreza I, Brammer M (1990) Brain membrane fluidity and lipid peroxidation in Alzheimer’s disease. Neurosci Lett 112: 333–337 ArticlePubMedCAS Google Scholar
Harman D (1956) Ageing: a theory based on free radical and rediation chemistry. J Gerontol 11: 298–300 ArticlePubMedCAS Google Scholar
Hoyer S (1996) Oxidative metabolism deficiencies in brains of patients with Alzheimer’s disease. Acta Neuropathol Scand [Suppl] 165: 18–24 ArticleCAS Google Scholar
Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F, Penin F, Cuny G (1989) Lipid peroxidation and free radical scavengers in Alzheimer’s disease. Gerontology 35: 275–282 ArticlePubMedCAS Google Scholar
Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB 1990) Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases. J Neural Transm [PD-Sect] 2: 327–340 ArticleCAS Google Scholar
Kala SV, Hasinoff BB, Richardson JS (1996) Brain samples from Alzheimer’s patients have elevated levels of loosely bound iron. Int J Neurosci 86: 263–269 ArticlePubMedCAS Google Scholar
Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer’s disease. Brain Res 623: 142–146 ArticlePubMedCAS Google Scholar
Kawamata T, Tooyama I, Yamada T, Walker DG, McGeer PL (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 142: 1574–1585 PubMedCAS Google Scholar
Kish SJ, Morito CL, Hornykiewicz O (1986) Brain glutathione peroxidase in neurodegenerative disorders. Neurochem Pathol 4: 23–28 ArticlePubMedCAS Google Scholar
Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain of Alzheimer’s disease. Neurology 45: 1594–1601 ArticlePubMedCAS Google Scholar
Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW (1992) Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89: 5462–5466 ArticlePubMedCAS Google Scholar
Makar TK, Cooper AJ, Tofel-Grehl B, Thaler HAT, Blass JP (1995) Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain. Neurochem Res 20: 705–711 ArticlePubMedCAS Google Scholar
Margaglione M, Garofano R, Cirillo F, Ruocco A, Grandone E, Vecchione G, Milan G, di Minno G, de Blasi A, Postiglione A (1995) Cu/Zn superoxide dismutase in patients with non-familial Alzheimer’s disease. Aging Milano 7: 49–54 PubMedCAS Google Scholar
Markesberry W, Ehmann WD (1994) In: Terry RD, Katzman R, Bick L (eds) Alzheimer’s disease. Raven Press, New York, pp 353–367 Google Scholar
Marklund SL, Adolffson R, Gottfries CG, Winblad B (1985) Superoxide isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J Neurol Sci 67: 319–325 ArticlePubMedCAS Google Scholar
Marttila RJ, Röytta M, Lorentz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in the human brain. J Neural Transm 74: 87–95 ArticlePubMedCAS Google Scholar
Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 379–389 Google Scholar
McCord J, Fridovich I (1988) Superoxide dismutase: the first twenty Years (1968–1988). Free Radic Biol Med 5: 363–369 ArticlePubMedCAS Google Scholar
McMillian M, Kong LY, Sawin SM, Wilson B, Das K, Hudson P, Hong JS, Bing G (1995) Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem Biophys Res Commun 215: 572–577 ArticlePubMedCAS Google Scholar
Metcalfe T, Bowen DM, Müller DP (1989) Vitamin E concentrations in human brain from patients with Alzheimer’s disease, fetuses with Down’s syndrome, cetenarians, and controls. Neurochem Res 14: 1209–1212 ArticlePubMedCAS Google Scholar
Meccoci P, MacGarvey MS, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36: 747–751 Article Google Scholar
Morris CM, Candy JM, Kerwin JM, Edwardson JA (1994) Transferrin receptors in the normal human hippocampus and in Alzheimer’s disease. Neuropathol Appl Neurobiol 20: 473–477 ArticlePubMedCAS Google Scholar
Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism of accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 923–929 Article Google Scholar
Nitsch RM, Pittas AG, Blusztajin JK, Slack BE, Growdon HJ (1991) Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer’s disease. Ann NY Acad Sci 640: 110–113 PubMedCAS Google Scholar
Nitsch RM, Blusztajin JK, Pittas AG, Slack BE, Growdon JH, Wurtman RD (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci 89: 1671–1675 ArticlePubMedCAS Google Scholar
Oreland L, Gottfries CG (1986) Brain monoamine oxidase in aging and in dementia of Alzheimer type. Prog Neuropsychopharmacol Biol Psychiatry 10: 533–540 ArticlePubMedCAS Google Scholar
Palmer AM, Burns MA (1994) Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer’s disease. Brain Res 645: 338–342 ArticlePubMedCAS Google Scholar
Perl DP, Good PF (1992) Aluminium and the neurofibrillary tangle: results of tissue microprobe studies. Ciba Found Symp 169: 217–227 PubMedCAS Google Scholar
Perrin R, Briancon S, Jaendel C, Artur Y, Min A, Penin F, Siest G (1990) Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer’s disease: a case-control study. Gerontology 36: 306–313 ArticlePubMedCAS Google Scholar
Quinlan GJ, Halliwell B, Moorhouse CP, Gutteridge JMC (1988) Action of lead(II) and aluminium(III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions. Biochim Biophys Acta 962:196–200 ArticlePubMedCAS Google Scholar
Richardson JS (1993) Free radicals in the genesis of Alzheimer’s disease. Ann NY Acad Sci 695: 73–76 ArticlePubMedCAS Google Scholar
Riederer P, Youdim MBH (1993) The therapeutic place and value of present and future MAO-B inhibitors — L-deprenyl as the gold standard. In: Szeleny I (ed) Inhibitors of monoamine oxidase B. Pharmacology and clinical use in neurodegenerative disorders. Birkhäuser, Basel, pp 327–338 Google Scholar
Selkoe DJ, Ihara Y, Salazar F (1982) Alzheimer disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science 215: 1243–1245 ArticlePubMedCAS Google Scholar
Shaw PJ (1992) Excitatory amino acid neurotransmission, excitotoxicity and excitotoxins. Curr Opin Neurol Neurosurg 5: 383–390 PubMedCAS Google Scholar
Smith CD, Corney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein peroxidation and enzyme dysfunction in normal aging and Alzheimer’s disease. Am J Pathol 145: 42–47 Google Scholar
Smith MA, Taneda S, Richey PL, Yan S-D, Sayre LM, Monnier VM, Perry G (1994) Advanced Mallard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710–5714 ArticlePubMedCAS Google Scholar
Smith MA, Sayre L, Perry G (1995a) Is Alzheimer’s a disease of oxidative stress? Alz Dis Rev 1: 63–67 Google Scholar
Smith MA, Sayre ML, Monnier VM, Perry G (1995b) Radical AGEing in Alzheimer’s disease. Trends Neurosci 18: 172–176 ArticlePubMedCAS Google Scholar
Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996a) Oxidative damage in Alzheimer’s. Nature 382: 120–121 ArticlePubMedCAS Google Scholar
Smith MA, Sayre ML, Monnier VM, Perry G (1996b) Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenetic role in the formation of senile plaques and neurofibrillary tangles. Mol Chem Neuropathol 28: 41–48 ArticlePubMedCAS Google Scholar
Sofic E, Frölich L, Riederer P, Jellinger K, Heckers S, Beckmann H, Deinzer E, Pantucek F, Hebenstreit G, Ransmayr (1991) Biochemical membrane constituents and activities of alkaline and acid phosphatase and cathepsin in cortical and subcortical brain areas in dementia of the Alzheimer type. Dementia 2: 39–44 Google Scholar
St George-Hyslop PH, Haines JL, Farrer, Polinsky R, van Broeckhoven C, Goate A, McLachlan DR, Orr H, Bruni HC (1990) Genetic linkage studies suggest that Alzheimer’s disease is not a single homogeneous disorder. FAD Collaborative Study Group. Nature 347: 194–197 ArticlePubMedCAS Google Scholar
Subbarao KV, Richardson JS, Ang LC (1990) Autopsy samples of Alzheimer’s cortex show increased lipid peroxidation in vitro. J Neurochem 55: 342–345 ArticlePubMedCAS Google Scholar
Sulkava R, Nordberg UR, Erkinjuntti T, Westermarck T (1986) Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer’s disease and other dementias. Acta Neurol Scand 73: 487–489 Google Scholar
Thome J, Kornhuber J, Münch G, Schinzel R, Taneli Y, Zielke B, Rösler M, Riederer P (1996) Neue Hypothese zur Athiopathogenese des Alzheimer-Syndroms — Advanced glycation end products (AGEs). Nervenarzt 67: 924–929 ArticlePubMedCAS Google Scholar
Thome J, Zhang J, Davids E, Foley P, Weijers H-G, Wiesbeck GA, Böning J, Riederer P, Gerlach M (1997a) Evidence for increased oxidative stress in alcohol-dependent patients provided by quantification of in vivo salicylate hydroxylation products. Alcohol Clin Exp Res 21: 82–85 ArticlePubMedCAS Google Scholar
Thome J, Gsell W, Rösier M, Kornhuber J, Frölich L, Hashimoto E, Zielke B, Wiesbeck GA, Riederer P (1997b) Oxidative-stress associated parameters (lactoferrin, superoxide dismutase) in serum of patients with Alzheimer’s disease. Life Sci 60: 13–19 ArticlePubMedCAS Google Scholar
Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE (1988) Regional brain trace-element studies in Alzheimer’s disease. Neurotoxicology 9: 1–7 PubMedCAS Google Scholar
Troncoso JC, Costello A, Watson AL, Johnson GVW (1993) In vitro polymerization of oxidized tau into filaments. Brain Res 613: 313–316 ArticlePubMedCAS Google Scholar
Urakami K, Sato K, Okada A, Mura T, Shimomura T, Takenaka T, Wakutani Y, Oshima T, Adachi Y, Takahashi K et al. (1995) Cu, Zn superoxide dismutase in patients with dementia of the Alzheimer type. Acta Neurol Scand 91: 165–168 ArticlePubMedCAS Google Scholar
van Rensburg SJ, Carstens ME, Potocnik FC, van der Spuy G, van der Walt BJ, Taljaard JJ (1995) Transferrin C2 and Alzheimer’s disease: another piece of the puzzle found? Med Hypotheses 44: 268–272 ArticlePubMed Google Scholar
Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91: 4766–4770 ArticlePubMedCAS Google Scholar
Vlassara H, Li YM, Imani F, Wojciechowicz D, Yang Z, Liu FT, Cerami A (1995) Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1:634–646 PubMedCAS Google Scholar
Wallace DC (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256: 628–632 ArticlePubMedCAS Google Scholar
Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-b peptide neurotoxicity in Alzheimer’s disease. Nature 382: 685–691 ArticlePubMedCAS Google Scholar
Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC (1992) Plasma concentrations of vitamins A and E and carotenoids in Alzheimer’s disease. Age Ageing 21: 91–94 ArticlePubMedCAS Google Scholar
Zemlan FP, Thienhaus OJ, Bosmann HB (1989) Superoxide dismutase activity in Alzheimer’s disease: possible mechanism for paired helical filament formation. Brain Res 476: 160–162 ArticlePubMedCAS Google Scholar
Zhou Y, Richardson JS, Mombourquette MJ, Weil JA (1995) Free radical formation in autopsy samples of Alzheimer and control cortex. Neurosci Lett 195: 89–92 ArticlePubMedCAS Google Scholar
Zoccarato F, Cavallini L, Deana R, Alexandre A (1988) Pathways of hydrogen peroxide generation in guinea pig cerebral cortex mitochondria. Biochem Biophy Res Commun 154: 727–734 ArticleCAS Google Scholar